Our results demonstrated positive expression of cannabinoid receptors, CB1 and CB2, in both canine and human NHL cell lines, with a significantly higher expression in canine and human B-cell lymphoma compared to canine T-cell lymphoma. This evidence concerns the gene CNR2 and non-Hodgkin lymphoma.